Hernández LGD, Gutiérrez GCE, Ramos BLM, Villagómez OAJ, Cabrera RA, Reyes SG

Language: Spanish
References: 24
Page: 44-49
PDF size: 65.04 Kb.

ABSTRACT

Bacterial meningitis (BM) is a medical, neurological, and sometimes neurosurgical emergency that requires a multidisciplinary approach. Has an annual incidence of 4 to 6 cases per 100,000 adults, and his mortality is very high perhaps to count with antimicrobials effective. The classical clinical manifestations of bacterial meningitis in adults are fever, headache, neck stiffnes, and signs of cerebral dysfunction, and usually are present in more than 80% percent of the cases. The cerebral dysfunction is to show by confusion, delirium or reduce of level consciousness. The diagnosis is based on the cerebrospinal study. Gram’s staining of cerebrospinal fluid allow the rapid identification of the causative organism in 60 to 90 percent of the cases. The initial treatment approach to the patient with suspected acute bacterial meningitis depends on early recognition of the meningitis syndrome, rapid diagnostic evaluation, and emergent antimicrobial and adjunctive therapy. The empirical therapy is based on the cephalosporin plus vancomycin administration while the culture of cerebrospinal fluid is obtained. The adjuvant therapy with dexamethasone reduce the frequency of neurologic sequelae among survivors.

REFERENCES

1. van de Beek, De Gans J, Tunkel A, et al. Community-Acquired Bacterial Meningitis in Adults. N Engl J Med 2006; 354: 44- 53.

2. Hussein AS, Shafran SD. Acute bacterial meningitis in adults: a 12-year review. Medicine 2000; 79: 360-8.

3. Sigurdardottir B, Bjornsson OM, Erlendsdottir H, et al. Acute bacterial meningitis in adults: a 20-year overview. Arch Intern Med 1997; 157: 425-30.

4. Morton NS. Bacterial meningitis. A view of the past 90 years. N Engl J Med 2004; 351: 1826-8.

5. Kastenbauer S, Pfister HW. Pneumococcal meningitis in adults: spectrum of complications and prognostic factors in a series of 87 cases. Brain 2003; 126: 1015-25.

6. Flores-Cordero JM, Amaya-Villar R, Rincon-Ferrari MD, et al. Acute community-acquired bacterial meningitis in adults admitted to the intensive care unit: clinical manifestations, management and prognostic factors. Intensive Care Med 2003; 29: 1967-73.

7. Attia J, Hatala R, Cook DJ, Wong JG. The rational clinical examination: does this adult patient have acute meningitis? JAMA 1999; 282: 175-81.

8. Van de Beek D, De Gans J, Spanjaard L, et al. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 2004; 351: 1849-59.

9. Gray LD, Fedorko DP. Laboratory diagnosis of bacterial meningitis. Clin Microbiol Rev 1992; 5: 130-45.

10. van Crevel H, Hijdra A, de Gans J. Lumbar puncture and the risk of herniation: when should we first perform CT? J Neurol 2002; 249: 129-37.

11. Chapin-Robertson K, Dahlberg SE, Edberg SC. Clinical and laboratory analyses of cytospin-prepared Gram stains for recovery and diagnosis of bacteria from sterile body fluids. J Clin Microbiol 1992; 30: 377-80.

12. Tarafdar K, Rao S, Recco RA, et al. Lack of sensitivity of the latex agglutination test to detect bacterial antigen in the cerebrospinal fluid of patients with culture-negative meningitis. Clin Infect Dis 2001; 33: 406-8.

13. Hasbun R, Abrahams J, Jekel J, et al. Computed tomography of the head before lumbar puncture in adults with suspected meningitis. N Engl J Med 2001; 345: 1727-33.

14. Genton B, Berger JP. Cerebrospinal fluid lactate in 78 cases of adult meningitis. Intensive Care Med 1990; 16: 196-200.

15. Ramers C, Billman G, Hartin M, et al. Impact of a diagnostic cerebrospinal fluid enterovirus polymerase chain reaction test on patient management. JAMA 2000; 283: 2680-5.

16. Gerdes LU, Jorgensen PE, Nexo E, Wang P. C-reactive protein and bacterial meningitis: a meta-analysis. Scand J Clin Lab Invest 1998; 58: 83-93.

17. Schwarz S, Bertram M, Schwab S, et al. Serum procalcitonin levels in bacterial and abacterial meningitis. Crit Care Med 2000; 28: 1828-32.

18. Aronin SI, Peduzzi P, Quagliarello VJ. Community-acquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing. Ann Intern Med 1998; 129: 862-9.

19. van de Beek D, de Gans J, Spanjaard L, et al. Antibiotic guidelines and antibiotic use in adult bacterial meningitis in The Netherlands. J Antimicrob Chemother 2002; 49: 661-6.

20. Tunkel A, Hartman B, Kaplan S, et al. Practice Guidelines for the management of bacterial meningitis Allan R. Clin Infect Dis 2004; 39: 1267-84.

21. van de Beek D, Schmand B, de Gans J, et al. Cognitive impairment in adults with good recovery after bacterial meningitis. J Infect Dis 2002; 186: 1047-52.

22. Schmidt H, Heimann B, Djukic M, et al. Neuropsychological sequelae of bacterial and viral meningitis. Brain 2006; 129: 333-45.

23. van de Beek D, de Gans J. Prognostic factors in adults with bacterial meningitis. N Engl J Med 2005; 352: 514.

24. de Gans J, van de Beek D. European dexamethasone in adulthood bacterial meningitis study investigators. Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002; 347: 1549-56.